The State of Nordic Private Equity 2025
EQT is the leading Nordics-headquartered investor, with an estimated €92.9 billion in enterprise value across Europe; the largest 50 Nordic HQ'd investors manage €193 billion.
Company · DK · 2 documents
EQT is the leading Nordics-headquartered investor, with an estimated €92.9 billion in enterprise value across Europe; the largest 50 Nordic HQ'd investors manage €193 billion.
The global biotechnology market was valued at about $1224.31 billion in 2022 and is expected to grow at a compound annual growth rate of 12.8% between 2023 and 2030.